☰

Olesya Chornoguz, Ph.D. - Publications

Affiliations: 
2012 Biological Sciences University of Maryland, Baltimore County, Baltimore, MD, United States 
Area:
Immunology, Biochemistry
Tree Info Similar researchers PubMed Report error

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Chornoguz O, Leettola CN, Leander K, Brosnan K, Emmell E, Chiu ML, Santulli-Marotto S. Characterization of a Novel Bispecific Antibody That Activates T Cells and Slows Tumor Growth . Monoclonal Antibodies in Immunodiagnosis and Immunotherapy. 38: 242-254. PMID 31825302 DOI: 10.1089/mab.2019.0035  0.423
2017 Sabins NC, Chornoguz O, Leander K, Kaplan F, Carter R, Kinder M, Bachman K, Verona R, Shen S, Bhargava V, Santulli-Marotto S. TIM-3 Engagement Promotes Effector Memory T Cell Differentiation of Human Antigen-Specific CD8 T Cells by Activating mTORC1. Journal of Immunology (Baltimore, Md. : 1950). PMID 29127145 DOI: 10.4049/jimmunol.1701030  0.375
2017 Chornoguz O, Hagan RS, Haile A, Arwood ML, Gamper CJ, Banerjee A, Powell JD. mTORC1 Promotes T-bet Phosphorylation To Regulate Th1 Differentiation. Journal of Immunology (Baltimore, Md. : 1950). PMID 28424242 DOI: 10.4049/Jimmunol.1601078  0.431
2013 Ostrand-Rosenberg S, Sinha P, Beury DW, Chornoguz O, Parker KH. Tumor-induced Myeloid-derived Suppressor Cells Cancer Immunotherapy: Immune Suppression and Tumor Growth: Second Edition. 473-496. DOI: 10.1016/B978-0-12-394296-8.00028-2  0.582
2012 Chornoguz O, Gapeev A, O'Neill MC, Ostrand-Rosenberg S. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients. Molecular & Cellular Proteomics : McP. 11: 1457-67. PMID 22942358 DOI: 10.1074/Mcp.M112.019232  0.499
2012 Ostrand-Rosenberg S, Sinha P, Chornoguz O, Ecker C. Regulating the suppressors: apoptosis and inflammation govern the survival of tumor-induced myeloid-derived suppressor cells (MDSC). Cancer Immunology, Immunotherapy : Cii. 61: 1319-25. PMID 22546994 DOI: 10.1007/S00262-012-1269-6  0.658
2011 Sinha P, Chornoguz O, Clements VK, Artemenko KA, Zubarev RA, Ostrand-Rosenberg S. Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL. Blood. 117: 5381-90. PMID 21450901 DOI: 10.1182/Blood-2010-11-321752  0.648
2011 Chornoguz O, Grmai L, Sinha P, Artemenko KA, Zubarev RA, Ostrand-Rosenberg S. Proteomic pathway analysis reveals inflammation increases myeloid-derived suppressor cell resistance to apoptosis. Molecular & Cellular Proteomics : McP. 10: M110.002980. PMID 21191032 DOI: 10.1074/Mcp.M110.002980  0.617
2010 Sinha P, Chornoguz O, Clements VK, Artemenko K, Zubarev RA, Ostrand-Rosenberg S. Abstract 5312: Myeloid-derived suppressor cells express the death receptor Fas and apoptose in response to T cell-expressed FasL Cancer Research. 70: 5312-5312. DOI: 10.1158/1538-7445.Am10-5312  0.661
Show low-probability matches.